FormFactor Shares Rise Amid High Valuation Concerns

FormFactor Inc. shares climbed 6.2% to close at $118.38, extending a one-year gain of 228.5%. While the semiconductor test equipment maker displays strong financial health, its current trading price sits well above intrinsic value estimates, raising questions about future returns.
FormFactor Inc. (FORM) saw its stock price increase by 6.2% on September 18, 2026, closing the session at $118.38. This move contributes to a substantial one-year performance gain of 228.5%, positioning the stock within a broad 52-week range that spans from a low of $33.77 to a high of $160.27. Despite the strong recent momentum, the current share price reflects a significant premium relative to historical norms and intrinsic value metrics.
The surge occurs against a backdrop of diverging signals regarding the company's worth. While the business demonstrates robust financial strength and solid growth fundamentals, valuation indicators suggest the market may be pricing in excessive future growth. This disconnect between operational performance and share price creates a complex investment landscape for holders of the semiconductor test equipment manufacturer.
Valuation Metrics Indicate Premium Pricing
FormFactor's current valuation stands out as a primary concern for investors. The company's trailing twelve-month price-to-earnings ratio (P/E) is 81.1x, which is nearly double its five-year median P/E of 41.8x. This historical comparison indicates that the stock is trading at a significant premium to its typical valuation levels. The forward P/E ratio sits at 31.6x, suggesting that even with expected future earnings growth, the multiple remains elevated compared to the company's historical average.
According to data cited by GN stocks/shares-surge, the stock is priced 101.5% above an intrinsic value estimate of $58.76. This substantial gap implies that the current market price does not align with conservative fundamental projections. When a stock trades at more than double its calculated fair value, the margin of safety for new investors is significantly reduced, increasing the risk of downward price correction if growth expectations are not met.
Financial Strength Contrasts With Low Valuation Score
Despite the valuation concerns, FormFactor exhibits strong underlying business fundamentals. A composite quality score of 70 out of 100 reflects above-average overall company health. Within this assessment, financial strength receives a perfect 10/10 rating, highlighting the company's robust balance sheet and liquidity position. Growth metrics also perform well, earning an 8/10 rating, which underscores the company's ability to expand its revenue base and maintain operational efficiency.
However, the valuation sub-score is rated just 1/10, signaling extreme pricing pressure relative to earnings. Profitability is rated 7/10, indicating solid margins, while momentum scores lower at 3/10. This low momentum rating suggests that despite the recent price surge, broader investor confidence and trading volume trends may not fully support the current premium. The disparity between the high financial strength score and the low valuation score creates a tension in the investment case, where strong operations are offset by an expensive entry point.
Insider Selling Signals Cautious Sentiment
Activity from company insiders provides additional context for the stock's current trajectory. Over the past 12 months, insiders have sold $22.1 million worth of FormFactor shares. Notably, there has been no corresponding insider buying activity during this period. This net selling trend by individuals with direct knowledge of the company's operations may indicate a cautious stance regarding the long-term value of the shares at current price levels.
Investor sentiment among professional funds remains mixed. Eleven gurus currently hold positions in FormFactor, with seven increasing their stakes and five reducing theirs. This split reaction suggests that while some long-term investors see value in the company's growth potential, others are taking profits or reducing exposure due to the elevated valuation. The absence of insider buying alongside this mixed institutional activity highlights the uncertainty surrounding the stock's future performance relative to its current price.






